Divis Laboratories reported its financial results for the first quarter of FY25, showing a notable increase in revenue and net profit. The company's revenue rose to Rs. 2,118 crore, a 19.1% year-on-year increase from Rs. 1,778 crore. Net profit for the quarter stood at Rs. 430 crore, marking a 21% rise from the same period last year. However, these figures fell short of market expectations, with the CNBC-TV18 poll predicting a net profit of Rs. 486.6 crore and revenue of Rs. 2,191 crore. Additionally, Divis Laboratories reported an EBITDA of Rs. 622 crore, below the expected Rs. 659 crore, and a margin of 29.4%, slightly under the anticipated 30.1%. The financial results were unaudited and pertained to the quarter ended June 30, 2024.
#DivisLaboratories June quarter net profit at Rs 430 crore, up 21% year-on-year. #DivisLaboratories' first-quarter profit rises in-line with market estimates.
#EarningsWithMC | Pharma giant Divis Labs declared 21% year-on-year rise in net profit to Rs 430 crore in the first quarter of FY25. 📈 Read on 👇 https://t.co/AqDElNZmu4 #Pharma #Earnings #Q1Results
DIVI'S LABORATORIES LTD. #DIVISLAB Unaudited Financial Results For The Quarter Ended June 30, 2024 https://t.co/PCYSJ5td4H